Clinical Trial Update: Dual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

This is a Phase 1/2 clinical trial evaluating dual-target CAR-NK cells for biomarker-selected advanced colorectal cancer that is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Colon
• Colorectal Cancer

Drugs mentioned

• Dual-Target CAR-NK Cells

Snippet

Sponsor: Beijing Biotech | Conditions: Colorectal Cancer Metastatic, Adenocarcinoma of Colon | Phase 1, Phase 2 | Status: RECRUITING